2014
DOI: 10.1002/cncy.21401
|View full text |Cite
|
Sign up to set email alerts
|

Cytopathology of pediatric malignancies: Where are we today with fine‐needle aspiration biopsies in pediatric oncology?

Abstract: Pediatric malignancies are uncommon and many have overlapping morphologic features, which together present diagnostic challenges. Cytopathology is recognized as an accurate and cost-effective modality for the diagnosis of pediatric malignancies in resource-limited countries, but is underused for this purpose in the United States. This review focuses on the cytopathology of pediatric malignancies with the goal of demystifying cytologic diagnoses of these entities. Differences between malignancies in young patie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
5
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
4
4

Relationship

1
7

Authors

Journals

citations
Cited by 11 publications
(5 citation statements)
references
References 25 publications
0
5
0
Order By: Relevance
“…FNAC has been used as a pathologic diagnostic procedure for over 60 years and has been proven to be an inexpensive, prompt, accurate and less technically demanding way of obtaining a specimen for diagnosis[ 8 12 ].Due to its simplicity, low complication rate, cost effectiveness and high patient acceptance, FNAC is a valuable tool in RLC where other diagnostic modalities are limited. FNAC provides a definitive tissue diagnosis to fill in the gap for many diagnostic dilemmas[ 8 12 ] especially when used in conjunction with cell block and IHC studies. In some countries, FNAC has been approved as the first line diagnostic tool for palpable superficial lesions[ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…FNAC has been used as a pathologic diagnostic procedure for over 60 years and has been proven to be an inexpensive, prompt, accurate and less technically demanding way of obtaining a specimen for diagnosis[ 8 12 ].Due to its simplicity, low complication rate, cost effectiveness and high patient acceptance, FNAC is a valuable tool in RLC where other diagnostic modalities are limited. FNAC provides a definitive tissue diagnosis to fill in the gap for many diagnostic dilemmas[ 8 12 ] especially when used in conjunction with cell block and IHC studies. In some countries, FNAC has been approved as the first line diagnostic tool for palpable superficial lesions[ 13 ].…”
Section: Introductionmentioning
confidence: 99%
“…This is likely due to the fact that hematopoietic neoplasms are quite common in young patients, comprising 30-45% of all childhood malignancies [9,10]. As in other studies [11,12,13,14], most of these FNA were from lesions in the head and neck and were diagnostic of benign/reactive lymphoid hyperplasia with cellular polymorphous lymphocytes, tingible body macrophages, and dendritic cells [9,10]. The exact etiology in the majority of cases of reactive lymphoid hyperplasia is unknown [15,16]; however, some malignancies such as Hodgkin lymphoma can have a heterogeneous or benign background, which can make the diagnosis challenging [9].…”
Section: Discussionmentioning
confidence: 51%
“…Primitive neuroectodermal tumor of the kidney is immunoreactive for CD99 and negative for WT1 [15]. Metanephric adenoma is positive for WT1 and negative for EMA [16]. Compared to these neoplasias, RO neither express neuroendocrine markers, nor WT1 and CD99.…”
Section: Discussionmentioning
confidence: 99%
“…Compared to these neoplasias, RO neither express neuroendocrine markers, nor WT1 and CD99. Solid variant of papillary RCC is positive for EMA and alpha-methylacyl-CoA racemase and negative for WT1 [16]. The latter immunoprofile is also consistent with RO, however, papillary RCC is mostly positive for vimentin and RCC antigen, which are usually negative in RO [17].…”
Section: Discussionmentioning
confidence: 99%